A carregar...
Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition
Lysine specific demethylase-1 (LSD1) has been shown to be critical in acute myeloid leukemia (AML) pathogenesis and this has led to the development of LSD1 inhibitors (LSD1i) which are currently tested in clinical trials. Nonetheless, preclinical studies reported that AML cells frequently exhibit in...
Na minha lista:
| Publicado no: | Haematologica |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ferrata Storti Foundation
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7395280/ https://ncbi.nlm.nih.gov/pubmed/31537694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2019.224501 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|